Drs. David Ilson, Sumanta (Monty) Pal, and Tian Zhang discuss new research presented at the 2022 ESMO Congress, including studies about treating liver, colorectal, stomach, kidney, bladder, and prostate cancers.
Effects of Patient Navigation, Lower-Cost Drug Alternatives on the Cost of Cancer Care and Rates of Metastatic Cancer Diagnoses and Deaths After Medicaid Expansion: Research from the 2022 ASCO Quality Care Symposium
Read research from the 2022 ASCO Quality Care Symposium, including studies on how cancer navigation programs and lower-cost drug alternatives can lower the cost of care and a study on how Medicaid expansion affected the rates of metastatic cancer diagnoses and cancer deaths.
2022 ASCO Annual Meeting Research Round Up: New Research in Lung Cancer, Lymphoma, and Childhood Cancers
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in non-small cell lung cancer, non-Hodgkin lymphoma, Ewing sarcoma, and neuroblastoma.
Dr. Manali I. Patel discusses what people with cancer should know about getting access to advances presented at scientific meetings, including questions to ask your health care team, why access to new advances may not be available right away, and how to get involved with cancer research.
In this podcast, Dr. Maryam Lustberg discusses 3 themes from the 2022 Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting, including insights on disparities in access to supportive care, the impacts of COVID-19 on the delivery of supportive care, and clinician burnout.
2022 ASCO Annual Meeting Research Round Up: New Research in Head and Neck Cancer, Brain Tumors, and Health Equity
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in head and neck cancer, brain tumors, and health equity.
Read research from the August 2022 session of the ASCO Plenary Series, which features a study that evaluated how common it is for people with lung cancer to have inherited genetic mutations known to increase cancer risk.
2022 ASCO Annual Meeting Research Round Up: Advances in Treating Multiple Myeloma, Breast Cancer, and Cancer in People 60 and Older
In this podcast, members of the American Society of Clinical Oncology (ASCO) discuss new research presented at the 2022 ASCO Annual Meeting in multiple myeloma, breast cancer, and cancer in people age 60 or older.
In this webinar, experts discuss new research in bladder cancer, kidney cancer, prostate cancer, and testicular cancer presented at the 2022 ASCO Annual Meeting and the 2022 Genitourinary Cancers Symposium.
2022 ASCO Annual Meeting: Using Biomarker Testing to Avoid Radiation Therapy in People 55+ With Luminal A Breast Cancer
The ASCO Annual Meeting is being held June 3 to 7, and here is some of notable research that will be presented today. Today’s research includes a study evaluating whether radiation therapy can be avoided after surgery for people aged 55 or older with low-grade luminal A breast cancer, as identified through biomarker testing.